Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-16
1986-04-15
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544263, 544366, A61K 3141, C07D48704
Patent
active
045828334
ABSTRACT:
This disclosure describes novel 2-(4-substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines useful as hypotensive agents.
REFERENCES:
patent: 4036840 (1977-07-01), O'Brien
patent: 4497814 (1985-02-01), Witkowski
Okabe et al., J. Heterocyclic Chemistry, 20, p. 735 (1983).
Miller & Rose, J. Chemical Society, 3357 (1965).
Dusza John P.
Meyer Walter E.
Tomcufcik Andrew S.
American Cyanamid Company
Benson Robert
Conroy, Jr. E. A.
Daus Donald G.
LandOfFree
2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1439118